本页面由Tiger Trade Technology Pte. Ltd.提供服务

PDS Biotechnology Corporation

1.46
+0.07505.43%
成交量:206.37万
成交额:299.46万
市值:1.05亿
市盈率:-2.27
高:1.48
开:1.48
低:1.39
收:1.38
52周最高:1.55
52周最低:0.1952
股本:7,247.42万
流通股本:5,805.64万
量比:6.59
换手率:3.55%
股息:- -
股息率:- -
每股收益(TTM):-0.6401
每股收益(LYR):-0.7437
净资产收益率:-543.97%
总资产收益率:-70.59%
市净率:-29.46
市盈率(LYR):-1.96

数据加载中...

公司资料

公司名字:
PDS Biotechnology Corporation
交易所:
NASDAQ
成立时间:
2005
员工人数:
21
公司地址:
303A College Road East,Princeton,New Jersey,United States
邮编:
08540
电话:
传真:
- -
简介:
PDS Biotechnology Corporation于2009年1月22日根据特拉华州法律成立。该公司是一家临床阶段的生物技术公司,专注于发现,开发和寻求商业化的新颖的以医院为基础的治疗方案,能够改变治疗模式和危及生命的管理。

董事

名称
职位
Frank Bedu Addo
Chief Executive Officer,Director and President
Stephen Glover
Chairman of the Board
Gregory Freitag
Independent Director
Ilian Iliev
Independent Director
Kamil Ali Jackson
Independent Director
Otis Brawley
Independent Director

股东

名称
职位
Frank Bedu Addo
Chief Executive Officer,Director and President
Stephan Toutain
Chief Operating Officer
Lars Boesgaard
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Spencer Brown
Senior Vice President, General Counsel, Corporate Secretary, and Compliance Officer
Gregory L. Conn
Chief Scientific Officer
Kirk Shepard
Chief Medical Officer